07/03/2019. Jan Ramaekers spoke to Sander Hoogendoorn in his 3FM morning broadcast on the decision of the FDA to approve a ketamine derived depression drug. Listen to podcast here (scroll to 1 hr 51 min)
07/03/2019. Jan Ramaekers spoke to Sander Hoogendoorn in his 3FM morning broadcast on the decision of the FDA to approve a ketamine derived depression drug. Listen to podcast here (scroll to 1 hr 51 min)
